DOBI Medical International, Inc. and United Telecoms
Limited Sign Sales Distribution Agreement for the ComfortScan™ System in
Agreement Calls For The Purchase Of 40 ComfortScan Systems In The Next 18 Months
Mahwah, NJ, June 22, 2004. DOBI Medical
International, Inc. (OTCBB:DBMI) today announced it has signed an
agreement with United Telecoms Limited (UTL) of Bangalore, India, for
the marketing, sale and service of DOBI Medical’s ComfortScan™ system in
the domestic Indian market. UTL is a diversified conglomerate with
interests in telecom products and networking, telemedicine, and banking.
The ComfortScan system is a non-invasive, non-ionizing, and gentle
dynamic optical imaging system designed to assist physicians in the
detection and management of breast cancer.
About DOBI Medical International,
CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Statements contained in this press release may contain information that includes or is based upon certain “forward-looking statements” within the meaning of the Securities Litigation Reform Act 1995 relating to the business of DOBI Medical. These forward-looking statements represent management’s current judgment and assumptions and can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are frequently accompanied by the use of such words as “anticipate”, “plans”, “believes”, “expects”, “project”, “intends”, or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties, including uncertainties relating to our ability to secure additional financing; success of product development efforts; our ability to timely meet federal, local and foreign government and industry regulations and standards; timely and successful completion of our patient clinical trials and submission of our pre-market approval application to the FDA; final approval of our ComfortScan system by the FDA; delays in the manufacturing process caused by our inabilities or the inabilities of our subcontractors to timely meet our specifications; our ability to establish international and domestic distribution networks, our ability to timely export our products to international markets; acceptance and use of our ComfortScan system by physicians, imaging clinics, and patients; our ability to obtain third party payer reimbursement; and our ability to compete on price and quality. Any one of these or other risks and uncertainties may cause actual results to be materially different from those described herein or elsewhere by us. Certain of these risks and uncertainties are or will be described in greater detail in our filings from time to time with the Securities and Exchange Commission, which we strongly urge you to read, including our 2003 Annual Report on Form 10-KSB/A and our Quarterly Report for the period ending March 31, 2004. Subsequent written and oral forward looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the cautionary statements and risk factors set forth above and elsewhere in our reports filed with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward looking statements.
For further information:
DOBI Medical International